307 related articles for article (PubMed ID: 35640803)
1. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system.
Jiang XC; Zhang T; Gao JQ
Adv Drug Deliv Rev; 2022 Aug; 187():114324. PubMed ID: 35640803
[TBL] [Abstract][Full Text] [Related]
2. Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing.
Duan L; Ouyang K; Wang J; Xu L; Xu X; Wen C; Xie Y; Liang Y; Xia J
Chembiochem; 2021 Dec; 22(24):3360-3368. PubMed ID: 34418266
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in extracellular vesicles for therapeutic cargo delivery.
Kim HI; Park J; Zhu Y; Wang X; Han Y; Zhang D
Exp Mol Med; 2024 Apr; 56(4):836-849. PubMed ID: 38556545
[TBL] [Abstract][Full Text] [Related]
4. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
Meng W; He C; Hao Y; Wang L; Li L; Zhu G
Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
[TBL] [Abstract][Full Text] [Related]
5. Engineered Cas9 extracellular vesicles as a novel gene editing tool.
Osteikoetxea X; Silva A; Lázaro-Ibáñez E; Salmond N; Shatnyeva O; Stein J; Schick J; Wren S; Lindgren J; Firth M; Madsen A; Mayr LM; Overman R; Davies R; Dekker N
J Extracell Vesicles; 2022 May; 11(5):e12225. PubMed ID: 35585651
[TBL] [Abstract][Full Text] [Related]
6. Current Strategies for Exosome Cargo Loading and Targeting Delivery.
Zeng H; Guo S; Ren X; Wu Z; Liu S; Yao X
Cells; 2023 May; 12(10):. PubMed ID: 37408250
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the development and establishment of exosome-based drug delivery systems.
Wang J; Chen D; Ho EA
J Control Release; 2021 Jan; 329():894-906. PubMed ID: 33058934
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
9. Measurement and standardization challenges for extracellular vesicle therapeutic delivery vectors.
Nelson BC; Maragh S; Ghiran IC; Jones JC; DeRose PC; Elsheikh E; Vreeland WN; Wang L
Nanomedicine (Lond); 2020 Sep; 15(22):2149-2170. PubMed ID: 32885720
[TBL] [Abstract][Full Text] [Related]
10. Exosomes: Structure, Biogenesis, Types and Application in Diagnosis and Gene and Drug Delivery.
Agarwal S; Agarwal V; Agarwal M; Singh M
Curr Gene Ther; 2020; 20(3):195-206. PubMed ID: 32787759
[TBL] [Abstract][Full Text] [Related]
11. Exosomes as New Generation Vehicles for Drug Delivery: Biomedical Applications and Future Perspectives.
Rajput A; Varshney A; Bajaj R; Pokharkar V
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364116
[TBL] [Abstract][Full Text] [Related]
12. Gene Editing by Extracellular Vesicles.
Kostyushev D; Kostyusheva A; Brezgin S; Smirnov V; Volchkova E; Lukashev A; Chulanov V
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33028045
[TBL] [Abstract][Full Text] [Related]
13. Application of exosome engineering modification in targeted delivery of therapeutic drugs.
Wang Y; Jiang M; Zheng X; He Y; Ma X; Li J; Pu K
Biochem Pharmacol; 2023 Sep; 215():115691. PubMed ID: 37481135
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.
Chen Z; Xiong M; Tian J; Song D; Duan S; Zhang L
J Nanobiotechnology; 2024 Jan; 22(1):18. PubMed ID: 38172932
[TBL] [Abstract][Full Text] [Related]
15. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications.
Amiri A; Bagherifar R; Ansari Dezfouli E; Kiaie SH; Jafari R; Ramezani R
J Transl Med; 2022 Mar; 20(1):125. PubMed ID: 35287692
[TBL] [Abstract][Full Text] [Related]
16. Exosomes as Potential Functional Nanomaterials for Tissue Engineering.
Yao Y; Jiang Y; Song J; Wang R; Li Z; Yang L; Wu W; Zhang L; Peng Q
Adv Healthc Mater; 2023 Jun; 12(16):e2201989. PubMed ID: 36253093
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
[TBL] [Abstract][Full Text] [Related]
18. Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting.
Kim SM; Yang Y; Oh SJ; Hong Y; Seo M; Jang M
J Control Release; 2017 Nov; 266():8-16. PubMed ID: 28916446
[TBL] [Abstract][Full Text] [Related]
19. Exosomes as Anticancer Drug Delivery Vehicles: Prospects and Challenges.
Zhang Y; Li J; Gao W; Xie N
Front Biosci (Landmark Ed); 2022 Oct; 27(10):293. PubMed ID: 36336863
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.
Sharma S; Masud MK; Kaneti YV; Rewatkar P; Koradia A; Hossain MSA; Yamauchi Y; Popat A; Salomon C
Small; 2021 Oct; 17(42):e2102220. PubMed ID: 34216426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
